Manchester Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $118 | Hold |
1
| – | – | ﹤0.01% | 1289 |
|
|
2025
Q4 | $164 | Hold |
1
| – | – | ﹤0.01% | 1318 |
|
|
2025
Q3 | $134 | Hold |
1
| – | – | ﹤0.01% | 1274 |
|
|
2025
Q2 | $125 | Hold |
1
| – | – | ﹤0.01% | 1185 |
|
|
2025
Q1 | $128 | Hold |
1
| – | – | ﹤0.01% | 1151 |
|
|
2024
Q4 | $144 | Hold |
1
| – | – | ﹤0.01% | 1134 |
|
|
2024
Q3 | $149 | Hold |
1
| – | – | ﹤0.01% | 1150 |
|
|
2024
Q2 | $127 | Hold |
1
| – | – | ﹤0.01% | 1131 |
|
|
2024
Q1 | $184 | Hold |
1
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q4 | $180 | Hold |
1
| – | – | ﹤0.01% | 979 |
|
|
2023
Q3 | $160 | Sell |
1
-50
| -98% | -$8.17K | ﹤0.01% | 972 |
|
|
2023
Q2 | $7.21K | Buy |
51
+1
| +2% | +$160 | ﹤0.01% | 578 |
|
|
2023
Q1 | $8.42K | Hold |
50
| – | – | ﹤0.01% | 565 |
|
|
2022
Q4 | $8.47K | Hold |
50
| – | – | ﹤0.01% | 483 |
|
|
2022
Q3 | $9K | Hold |
50
| – | – | ﹤0.01% | 460 |
|
|
2022
Q2 | $8K | Hold |
50
| – | – | ﹤0.01% | 515 |
|
|
2022
Q1 | $9K | Hold |
50
| – | – | ﹤0.01% | 558 |
|
|
2021
Q4 | $13K | Hold |
50
| – | – | ﹤0.01% | 533 |
|
|
2021
Q3 | $14K | Hold |
50
| – | – | ﹤0.01% | 557 |
|
|
2021
Q2 | $10K | Hold |
50
| – | – | ﹤0.01% | 498 |
|
|
2021
Q1 | $10K | Hold |
50
| – | – | ﹤0.01% | 486 |
|
|
2020
Q4 | $10K | Buy |
+50
| New | +$9.1K | ﹤0.01% | 482 |
|
|
2016
Q3 | – | Sell |
-3,000
| Closed | -$82K | – | 527 |
|
|
2016
Q2 | $82K | Hold |
3,000
| – | – | 0.01% | 320 |
|
|
2016
Q1 | $80K | Hold |
3,000
| – | – | 0.01% | 353 |
|
|
2015
Q4 | $85K | Hold |
3,000
| – | – | 0.01% | 345 |
|
|
2015
Q3 | $84K | Hold |
3,000
| – | – | 0.01% | 325 |
|
|
2015
Q2 | $124K | Buy |
+3,000
| New | +$110K | 0.02% | 265 |
|
|
2015
Q1 | – | Sell |
-7,245
| Closed | -$143K | – | 803 |
|
|
2014
Q4 | $143K | Hold |
7,245
| – | – | 0.02% | 445 |
|
|
2014
Q3 | $144K | Hold |
7,245
| – | – | 0.02% | 457 |
|
|
2014
Q2 | $165K | Sell |
7,245
-2,025
| -22% | -$36K | 0.02% | 422 |
|
|
2014
Q1 | $119K | Sell |
9,270
-5,790
| -38% | -$83K | 0.02% | 487 |
|
|
2013
Q4 | $205K | Hold |
15,060
| – | – | 0.03% | 332 |
|
|
2013
Q3 | $167K | Buy |
+15,060
| New | +$150K | 0.03% | 371 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Manchester Capital Management's RGEN Position: Q1 2026 in Review
Manchester Capital Management held its Repligen (RGEN) position steady in Q1 2026 at 1 share worth $118. The position accounts for ﹤0.01% of the portfolio, ranked #1289.
Manchester Capital Management first reported a position in RGEN in Q3 2013 and has held it in 33 quarters since. The position peaked at $205K in Q4 2013. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Manchester Capital Management held 1 share of Repligen worth $118 as of Q1 2026.
- Manchester Capital Management left its Repligen share count unchanged in Q1 2026.
- Repligen made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #1289 holding.
- Manchester Capital Management first reported a position in Repligen in Q3 2013 and has held it in 33 quarters since.
- Manchester Capital Management's Repligen position peaked at $205K in Q4 2013.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.